Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 95
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Short- and Long-Term Effects on Glucose Control of Nonadherence to Insulin Therapy in People With Type 2 Diabetes An In Silico Study 2024 Visentin, RobertoCobelli, ClaudioDalla Man, Chiara + JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY - -
Tailoring the Padova Type 2 Diabetes Simulator for Treatment Guidance in Target Populations 2024 Visentin, RobertoSchiavon, MicheleBonet, JacopoRiz, MichelaMan, Chiara Dalla + IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING - -
Increased Insulin Secretion and Glucose Effectiveness in Obese Patients with Type 2 Diabetes following Bariatric Surgery 2023 Visentin, RobertoDalla Man, Chiara + JOURNAL OF DIABETES RESEARCH - -
Modeling Doxorubicin Pharmacokinetics in Multiple Myeloma Suggests Mechanism of Drug Resistance 2023 Pedersen, Morten GramVisentin, Roberto + IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING - -
Model Assessment of Doxorubicin Pharmacokinetics in Multiple Myeloma 2023 M. BaldanM. G. PedersenR. Visentin + - - Proceedings of VIII National Congress of Bioengineering (GNB 2023)
SMART INSULIN THERAPY INITIATION IMPROVES GLUCOSE CONTROL IN INSULIN‐NAÏVE SUBJECTS WITH TYPE 2 DIABETES 2023 J. BonetR. VisentinM. VettorettiA. FacchinettiC. Dalla Man DIABETES TECHNOLOGY & THERAPEUTICS - Diabetes Technology & Therapeutics
Modeling Doxorubicin Treatment Effect in Multiple Myeloma 2023 Andrean D.Pedersen M. G.Visentin R. + - - EIGHTH NATIONAL CONGRESS OF BIOENGINEERING Proceedings
A PK/PD Simulation Model for Supporting Doxorubicin Therapy in Multiple Myeloma 2023 D. AndreanM. G. PedersenR. Visentin + MOLECULAR ONCOLOGY - EACR 2023: Innovative Cancer Science, 12-15 June 2023, Torino, Italy
Smart Titration of Long-Acting Insulin in Insulin-Naïve Type 2 Diabetic Subjects 2023 Jacopo BonetRoberto VisentinMartina VettorettiAndrea FacchinettiChiara Dalla Man - - EIGHTH NATIONAL CONGRESS OF BIOENGINEERING - Proceedings
Smart Insulin Therapy Initiation In Insulin-Naive Subjects With Type 2 Diabetes Using Machine Learning 2023 Jacopo BonetRoberto VisentinChiara Dalla Man JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY - Journal of Diabetes Science and Technology
IP-IP PADOVA SIMULATOR: INTRAPERITONEAL INSULIN DELIVERY AND GLUCOSE SENSING 2022 Lo Presti, JVisentin, RGalderisi, ACobelli, C + DIABETES TECHNOLOGY & THERAPEUTICS - DIABETES TECHNOLOGY & THERAPEUTICS
RESIDUAL B-CELL FUNCTION IN SUBJECTS WITH TYPE 2 DIABETES PROTECTS FROM NON-ADHERENCE TO INSULIN THERAPY VERSUS SUBJECTS WITH TYPE 1 DIABETES 2022 Visentin, RCobelli, CDalla Man, C + DIABETES TECHNOLOGY & THERAPEUTICS - DIABETES TECHNOLOGY & THERAPEUTICS
Glucose Controlin Type 2 Diabetes: In Silico Study of Sub-Optimal Adherence to Insulin Therapy 2022 Visentin R.Man C. D. + - - Proceedings of the 2022 10th International Conference on Systems and Control (ICSC)
1426-P: Increased Insulin Secretion and Glucose Effectiveness Result in Improved Glucose Tolerance in Obese Subjects Two Months after Gastric Bypass and Sleeve 2022 VISENTIN, ROBERTOMAN, CHIARA DALLA + DIABETES - -
A software interface for in silico testing of type 2 diabetes treatments 2022 Visentin R.Cobelli C.Dalla Man C. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE UPDATE - -
Editorial: Recent Advances in Computer Simulation for Diabetes Treatment and Care 2022 Visentin R. + FRONTIERS IN ENDOCRINOLOGY - -
IMPACT OF CARBOHYDRATE COUNTING ERROR ON GLUCOSE CONTROL DURING INSULIN THERAPY IN TYPE 2 DIABETES 2021 Visentin, RDalla Man, C + DIABETES TECHNOLOGY & THERAPEUTICS - DIABETES TECHNOLOGY & THERAPEUTICS
PERSONALIZED INSULIN BOLUS THERAPY INITIATION IN SUBJECTS WITH TYPE 2 DIABETES 2021 Visentin, RDalla Man, C + DIABETES TECHNOLOGY & THERAPEUTICS - DIABETES TECHNOLOGY & THERAPEUTICS
Modeling Pharmacokinetics of Doxorubicin in Multiple Myeloma Cells 2021 Giaretta A.Pedersen M. G.Visentin R. + - ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY 2021 43rd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC)
Determinants of hepatic insulin clearance – Results from a Mendelian Randomization study 2021 Dalla Man C.Visentin R. + METABOLISM, CLINICAL AND EXPERIMENTAL - -
Mostrati risultati da 1 a 20 di 95
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile